Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway.

Overexpression of Id family proteins inhibits cell differentiation and enhances cell proliferation and invasiveness. Although Id1 is the Id family member mostly linked to tumorigenesis, its role in lung cancer is unclear. An elevated Id1 expression was observed in lung cancer cell lines as well as lung cancer tissues. Id1 overexpression increased cell proliferation while Id1 knockdown decreased cell proliferation, mostly through Akt-related pathway. Nude mice study further confirmed an increased tumor growth in Id1-overexpressing cells and a decreased tumor growth in Id1-knockdowned cells. In conclusion, inactivation of Id1 may provide a novel strategy for treatment of lung cancer patients.

[1]  W. Forrester,et al.  Inhibition of an Erythroid Differentiation Switch by the Helix-Loop-Helix Protein Id1 (*) , 1995, The Journal of Biological Chemistry.

[2]  K. Pisters,et al.  Adjuvant chemotherapy in completely resected non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J D Norton,et al.  ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. , 2000, Journal of cell science.

[4]  K. Tokunaga,et al.  Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer , 2005, Cancer science.

[5]  R. Benezra,et al.  Id proteins in development, cell cycle and cancer. , 2003, Trends in cell biology.

[6]  S. Lippman,et al.  Molecular signatures of lung cancer--toward personalized therapy. , 2007, The New England journal of medicine.

[7]  S. Tsao,et al.  Evidence of increased Id‐1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells , 2002, Molecular carcinogenesis.

[8]  Tony Reiman,et al.  The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer. , 2010, Lung cancer.

[9]  J. Frederick,et al.  Impaired Immune Responses and B-Cell Proliferation in Mice Lacking the Id3 Gene , 1999, Molecular and Cellular Biology.

[10]  Huei-Mei Chen,et al.  A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. , 2011, Free radical biology & medicine.

[11]  D. Polsky,et al.  The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. , 2001, Cancer research.

[12]  Wang Yang.  DNA Repair by ERCC1 in Non-Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy , 2010 .

[13]  M. Brock,et al.  Id1 Promotes Tumor Cell Migration in Nonsmall Cell Lung Cancers , 2010, Journal of oncology.

[14]  C. Foster,et al.  Increased Expression of Id Family Proteins in Small Cell Lung Cancer and its Prognostic Significance , 2008, Clinical Cancer Research.

[15]  G. Srivastava,et al.  Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma , 2007, British Journal of Cancer.

[16]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[17]  M. Tsao,et al.  Molecular predictive and prognostic markers in non-small-cell lung cancer. , 2009, The Lancet. Oncology.

[18]  M. Ji,et al.  Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo , 2008, Oncogene.

[19]  S. Tsao,et al.  Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. , 2007, Carcinogenesis.

[20]  A. Iavarone,et al.  The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. , 1994, Genes & development.

[21]  R. Schilsky,et al.  Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  S. Tsao,et al.  Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. , 2002, Carcinogenesis.

[23]  F. Cappuzzo,et al.  Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer , 2009, Oncogene.

[24]  T. Jang,et al.  Id‐1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer , 2006, International journal of cancer.

[25]  H. Wakelee,et al.  Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer , 2011, Front. Oncol..

[26]  C. Malbon.  Developmental cell biology: G proteins in development , 2005, Nature Reviews Molecular Cell Biology.

[27]  M. Tschan,et al.  The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. , 2011, Lung cancer.

[28]  B. Nickoloff,et al.  The Helix–Loop–Helix Protein Id-1 Delays Onset of Replicative Senescence in Human Endothelial Cells , 2002, Laboratory Investigation.

[29]  M. Israel,et al.  Id gene expression as a key mediator of tumor cell biology. , 1999, Cancer research.

[30]  K. Chan,et al.  Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases , 2006, Modern Pathology.

[31]  P. Brown,et al.  Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. , 2006, Cancer letters.

[32]  Huei-Mei Chen,et al.  Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. , 2009, Cancer letters.

[33]  S. Ohlmeier,et al.  Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. , 2008, Journal of proteome research.

[34]  S. Tsao,et al.  Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth , 2002, Oncogene.

[35]  S. Tsao,et al.  Id‐1 promotes proliferation of p53‐deficient esophageal cancer cells , 2006, International journal of cancer.

[36]  Kyuhong Lee,et al.  Inhibitor of differentiation 1 (Id1) expression attenuates the degree of TiO2-induced cytotoxicity in H1299 non-small cell lung cancer cells. , 2009, Toxicology letters.

[37]  Sanda Šulić,et al.  Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. , 2005, Genes & development.